Skip to main content

DISTRIBUCION ESPACIAL DE ALTERACIONES GENOMICAS EN ‘TUMOR BUDS’ Y GRUPOS DE CELULAS POBREMENTE DIFERENCIADAS EN EL CANCER COLORRECTAL Y SU IMPLICACION EN LA EVASION INMUNE Y LA METASTASIS

PI20/00863

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)
Execution centre INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers

  • Pablo-Fontecha, Verónica|||0000-0001-9084-4597
  • Hernández-Illán, Eva
  • Reparaz, Andrea
  • Asensio, Elena
  • Morata, Jordi|||0000-0002-6146-4322
  • Tonda, Raúl
  • Lahoz, Sara|||0000-0002-4491-9911
  • Parra, Carolina
  • Lozano, Juan José
  • García-Heredia, Anabel
  • Martínez-Roca, Alejandro
  • Beltran i Agulló, Sergi|||0000-0002-2810-3445
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Jover, Rodrigo
  • Castells, Antoni|||0000-0001-8431-2033
  • Trullàs, Ramon
  • Podlesniy, Petar
  • Camps, Jordi|||0000-0003-2929-4228
Somatic single-nucleotide variants (SNVs) occur every time a cell divides, appearing even in healthy tissues at low frequencies. These mutations may accumulate as neutral variants during aging, or eventually, promote the development of neoplasia. Here, we present the SP-ddPCR, a droplet digital PCR (ddPCR) based approach that utilizes customized SuperSelective primers aiming at quantifying the proportion of rare SNVs. For that purpose, we selected five potentially pathogenic variants identified by whole-exome sequencing (WES) occurring at low variant allele frequency (VAF) in at-risk colon healthy mucosa of patients diagnosed with colorectal cancer or advanced adenoma. Additionally, two APC SNVs detected in two cancer lesions were added to the study for WES-VAF validation. SuperSelective primers were designed to quantify SNVs at low VAFs both in silico and in clinical samples. In addition to the two APC SNVs in colonic lesions, SP-ddPCR confirmed the presence of three out of five selected SNVs in the normal colonic mucosa with allelic frequencies ≤ 5%. Moreover, SP-ddPCR showed the presence of two potentially pathogenic variants in the distal normal mucosa of patients with colorectal carcinoma. In summary, SP-ddPCR offers a rapid and feasible methodology to validate next-generation sequencing data and accurately quantify rare SNVs, thus providing a potential tool for diagnosis and stratification of at-risk patients based on their mutational profiling.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer, A Multicenter Study

  • Liu, Qing|||0000-0003-1784-6400
  • López-Prades, Sandra|||0000-0001-8208-2959
  • Saez de Gordoa, Karmele|||0000-0001-8106-6121
  • Rodrigo Calvo, María Teresa|||0000-0001-6675-3425
  • Garcia Gerona, Mireia|||0000-0003-3445-9744
  • Ruiz Martin, Juan
  • Romo-Navarro, Ángel|||0000-0002-7094-8484
  • Pinilla Pagnon, Ignacio|||0000-0002-6120-8302
  • Tarragona, Jordi|||0000-0002-1459-4087
  • Otero Alén, Begoña|||0000-0002-2876-6732
  • Camps Polo, Jordi|||0000-0003-2929-4228
  • Archilla, Ivan|||0000-0002-2142-0608
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
Background/Objectives: Lymph node metastases (LNM) undetected by standard hematoxylin and eosin (H&E) have been associated with unfavorable prognosis in colorectal cancer. The One-Step Nucleic Acid Amplification (OSNA) assay has demonstrated superior sensitivity in detecting LNM compared to H&E. We aimed to assess the performance of OSNA in detecting LNM, as well as its prognostic value in rectal cancer (RC) patients. Methods: Lymph nodes (LNs) of patients from 15 centers were analyzed by both H&E and OSNA. The total tumor load (TTL) was defined as the sum of cytokeratin 19 mRNA copies/µL in all LNs from a surgical specimen, using a threshold of 250 copies/μL for OSNA positivity. Cox proportional hazard regression was used to assess the effect of TTL ≥ 250 or 6000 copies/μL on cancer-specific survival (CSS) and recurrence-free survival (RFS), with Firth's method applied to account for low event rate. Results: A total of 97 RC patients were included. Of these, 84 patients were eligible for survival analysis. The sensitivity and specificity of OSNA, compared to H&E, were 91.7% and 84.7%, respectively. TTL ≥ 6000 versus <6000 copies/μL was related to worse CSS and RFS. When dividing TTL into three groups: ≤250, 250-6000, and.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prognostic value of whole lymph node molecular analysis in colorectal cancer, a prospective multicenter study

  • Liu, Qing|||0000-0003-1784-6400
  • López-Prades, Sandra|||0000-0001-8208-2959
  • Saez de Gordoa, Karmele|||0000-0001-8106-6121
  • Tarragona, Jordi|||0000-0002-1459-4087
  • Machado, Isidro|||0000-0001-7318-1330
  • Maurel, Joan|||0000-0002-9413-5592
  • Camps, Jordi
  • Archilla, Ivan|||0000-0002-2142-0608
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Rodrigo Calvo, María Teresa|||0000-0001-6675-3425
  • Martin, Juan Ruiz
  • Romo, Angel
  • Pinilla, Ignacio
  • Berenguel, Maria del Mar
  • Bravo Infante, Raquel|||0000-0003-3870-9931
The online version contains supplementary material available at 10.1007/s10238-025-01936-0.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Tumour Cell Seeding to Lymph Nodes from In Situ Colorectal Cancer

  • Rodrigo Calvo, María Teresa|||0000-0001-6675-3425
  • Saez de Gordoa, Karmele|||0000-0001-8106-6121
  • López-Prades, Sandra|||0000-0001-8208-2959
  • Archilla, Ivan|||0000-0002-2142-0608
  • Díaz, Alba|||0000-0002-0456-7085
  • Berrios, Mario
  • Camps Polo, Jordi|||0000-0003-2929-4228
  • Musulén, Eva|||0000-0002-9667-6464
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
Lymph node (LN) metastasis is an important prognostic factor in colorectal cancer (CRC). We aimed to search for lymphatic vessels (LVs) in the lamina propria of 39 surgically resected in situ CRC, as well as to detect the presence of tumour burden in the regional LNs. We identified the presence of LVs in the mucosa of all tumours (39/39; 100%) using D240 immunostains. LNs were analysed by both H&E and a RT-PCR-based molecular method. All cases were pN0 with H&E, and the molecular assay detected the presence of low amounts of tumour burden in the LNs of 11/39 (28%) cases, with no clinical consequences at 1 to 5 years of follow-up. The amount of tumour burden in LNs has proven to be a prognostic factor. Despite the fact that pTis is considered to have little or no risk of LN metastasis, our results enabled to quantify the amount of tumour burden within LNs, which may help clinical management. Lymph node (LN) metastasis is an important prognostic factor in colorectal cancer (CRC). We aimed to demonstrate the presence of lymphatic vessels (LV) in the mucosa of in-situ (pTis) CRC, and of detectable tumour burden in regional LNs. This is an observational retrospective study of 39 surgically resected in situ CRCs. The number of LVs was evaluated in both pTis and normal mucosa using D2-40 immunostains. All LNs were assessed with both H&E and the One Step Nucleic Acid Amplification (OSNA) assay, and the results were correlated with clinicopathological features. D2-40 immunohistochemisty revealed LVs in the lamina propria of all pTis CRC (100%), being absent in normal mucosa. A median of 16 LNs were freshly dissected per patient, and all cases were pN0 with H&E. Molecular LN analysis with OSNA revealed the presence of low amounts of tumour burden in 11/39 (28%) cases (range 400 to 4270 CK19 mRNA copies/µL), which had no clinical consequences. This study demonstrates the presence of LVs in the lamina propria in 100% of pTis CRC, as well as the presence of low amounts of tumour burden in regional LNs, only detected by molecular methods. Given the prognostic value of LN tumour burden, its molecular quantification may help a patient's clinical management.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage colon cancer

  • Lahoz, Sara|||0000-0002-4491-9911
  • Archilla, Ivan|||0000-0002-2142-0608
  • Asensio, Elena
  • Hernández-Illán, Eva
  • Ferrer Menduiña, Queralt|||0000-0003-3177-4618
  • López-Prades, Sandra|||0000-0001-8208-2959
  • Nadeu, Ferran|||0000-0003-2910-9440
  • Rey Azpiri, Javier del|||0000-0001-7887-7871
  • Sanz-Pamplona, Rebeca
  • Lozano, Juan José
  • Castells, Antoni|||0000-0001-8431-2033
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Camps Polo, Jordi|||0000-0003-2929-4228
Optimal selection of high-risk patients with stage II colon cancer is crucial to ensure clinical benefit of adjuvant chemotherapy. Here, we investigated the prognostic value of genomic intratumor heterogeneity and aneuploidy for disease recurrence. We combined targeted sequencing, SNP arrays, fluorescence in situ hybridization, and immunohistochemistry on a retrospective cohort of 84 untreated stage II colon cancer patients. We assessed the clonality of copy-number alterations (CNAs) and mutations, CD8 + lymphocyte infiltration, and their association with time to recurrence. Prognostic factors were included in machine learning analysis to evaluate their ability to predict individual relapse risk. Tumors from recurrent patients displayed a greater proportion of CNAs compared with non-recurrent (mean 31.3% versus 23%, respectively; p = 0.014). Furthermore, patients with elevated tumor CNA load exhibited a higher risk of recurrence compared with those with low levels [ p = 0.038; hazard ratio (HR) 2.46], which was confirmed in an independent cohort (p = 0.004; HR 3.82). Candidate chromosome-specific aberrations frequently observed in recurrent cases included gain of the chromosome arm 13q (p = 0.02; HR 2.67) and loss of heterozygosity at 17q22-q24.3 (p = 0.05; HR 2.69). CNA load positively correlated with intratumor heterogeneity (R = 0.52; p < 0.0001). Consistently, incremental subclonal CNAs were associated with an elevated risk of relapse (p = 0.028; HR 2.20), which we did not observe for subclonal single-nucleotide variants and small insertions and deletions. The clinico-genomic model rated an area under the curve of 0.83, achieving a 10% incremental gain compared with clinicopathological markers (p = 0.047). In conclusion, tumor aneuploidy and copy-number intratumor heterogeneity were predictive of poor outcome and improved discriminative performance in early-stage colon cancer. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cytology Smears, An Enhanced Alternative Method for Colorectal Cancer pN Stage-A Multicentre Study

  • Diaz-Mercedes, Sherley|||0000-0002-8164-8639
  • Archilla, Ivan|||0000-0002-2142-0608
  • Lahoz, Sara|||0000-0002-4491-9911
  • Rodrigo Calvo, María Teresa|||0000-0001-6675-3425
  • López-Prades, Sandra|||0000-0001-8208-2959
  • Tarragona, Jordi|||0000-0002-1459-4087
  • Landolfi, Stefania|||0000-0002-1059-635X
  • Concha, Angel
  • Machado, Isidro|||0000-0001-7318-1330
  • Maurel, Joan|||0000-0002-9413-5592
  • Chic, Nuria
  • Castells, Antoni|||0000-0001-8431-2033
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Camps Polo, Jordi|||0000-0003-2929-4228
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
Recurrence of stage II (pT3-T4 pN0) colorectal cancer (CRC) occurs in about 15% of patients and it is often due to undetected lymph node (LN) metastases with conventional pathology haematoxylin and eosin (H&E) LN analysis. Despite more sensitive molecular methods of LN staging having proved to have prognostic value in stage II CRC, we aimed at determining whether the pN stage could be better assessed with LN cytology smears. We analysed 3936 LNs from 217 CRC surgical resections, using three methods, H&E, cytology smears, and the One Step Nucleic Acid Amplification (OSNA) molecular assay. We compared the pN stages obtained from both H&E and cytology, as well as with the OSNA results. We concluded that LN analysis with cytology smears not only enables performing the pN stage, but detects more LN metastases than H&E, with a similar detection rate to molecular methods. Cytology LN analysis would allow a better patient therapeutic management. Stage II colorectal cancer (CRC) recurrence remains a clinical problem. Some of these patients are true stage III CRC with a pN0 pathology stage. This large prospective multicentre cohort study aimed at evaluating the diagnostic ability of lymph node (LN) cytology smears to perform the pN stage and compare it with the conventional haematoxylin and eosin (H&E) pathology pN stage. Additionally, we used the One-Step Nucleic Acid Amplification (OSNA), a high-sensitive molecular method of LN staging. A total of 3936 fresh LNs from 217 CRC surgical specimens were examined by three methods, H&E, LN cytology smears, and OSNA. H&E detected 29% of patients with positive LNs, cytology smears 35%, and OSNA 33.2% (p < 0.0001). H&E and cytology concordantly classified 92.2% of tumours, and 88.5% between OSNA and H&E. Cytology had 96.8% sensitivity and 90.3% specificity to discriminate positive/negative patients compared to H&E (p = 0.004), and 87.3% sensitivity and 89% specificity when compared to OSNA (p = 0.56). Patients with positive LNs detected by any of the three methods had significantly worse disease-free and overall survival. We conclude that pN stage accuracy for detecting positive LNs is superior with LN cytological smears than with conventional H&E, which would enable a better pN stage and management of early-stage CRC patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53 -Mutated Metastatic Colorectal Cancer

  • Lahoz, Sara|||0000-0002-4491-9911
  • Rodríguez, Adela|||0000-0002-4899-6607
  • Fernández Barat, Laia|||0000-0001-7528-9636
  • Gorría, Teresa
  • Moreno, Reinaldo
  • Esposito, Francis|||0000-0002-5028-9637
  • Oliveres, Helena|||0000-0003-1801-1181
  • Albiol, Santiago
  • Saurí Nadal, Tamara|||0000-0002-7479-5120
  • Pesantez, David|||0000-0003-0257-8538
  • Riu-Viladoms, G.|||0000-0002-8259-0811
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Jares, Pedro
  • Pedrosa, Leire|||0000-0002-1852-4975
  • Pineda, Estela|||0000-0003-2128-747X
  • Castells, Antoni|||0000-0001-8431-2033
  • Prat, Aleix|||0000-0003-2377-540X
  • Maurel, Joan|||0000-0002-9413-5592
  • Camps Polo, Jordi|||0000-0003-2929-4228
The mutational status of certain genes can be useful to advance therapeutic decision making and clinical management of cancer patients. In metastatic colorectal cancer, current clinicopathological factors employed in clinical practice have low or modest individual effect on survival, leading to a poor ability to discriminate patients at high risk. Here, we obtained data from metastatic colorectal cancer patients undergoing molecular testing by targeted gene sequencing, and we identified SMAD4 and FBXW7 mutated genes as negative prognostic markers in TP53 -driven tumors, which also improved the predictive performance to discriminate high-risk patients beyond clinical factors alone. This negative prognostic impact of co-occurring SMAD4 / TP53 and FBXW7 / TP53 mutations was confirmed in an independent validation analysis using publicly available data. Next-generation sequencing (NGS) provides a molecular rationale to inform prognostic stratification and to guide personalized treatment in cancer patients. Here, we determined the prognostic and predictive value of actionable mutated genes in metastatic colorectal cancer (mCRC). Among a total of 294 mCRC tumors examined by targeted NGS, 200 of them derived from patients treated with first-line chemotherapy plus/minus monoclonal antibodies were included in prognostic analyses. Discriminative performance was assessed by time-dependent estimates of the area under the curve (AUC). The most recurrently mutated genes were TP53 (64%), KRAS or NRAS (49%), PIK3CA (15%), SMAD4 (14%), BRAF (13%), and FBXW7 (9.5%). Mutations in FBXW7 correlated with worse OS rates (p = 0.036; HR, 2.24) independently of clinical factors. Concurrent mutations in TP53 and FBXW7 were associated with increased risk of death (p = 0.02; HR, 3.31) as well as double-mutated TP53 and SMAD4 (p = 0.03; HR, 2.91). Analysis of the MSK-IMPACT mCRC cohort (N = 1095 patients) confirmed the same prognostic trend for the previously identified mutated genes. Addition of the mutational status of these genes upon clinical factors resulted in a time-dependent AUC of 87%. Gene set enrichment analysis revealed specific molecular pathways associated with SMAD4 and FBXW7 mutations in TP53 -defficient tumors. Conclusively, SMAD4 and FBXW7 mutations in TP53 -altered tumors were predictive of a negative prognostic outcome in mCRC patients treated with first-line regimens.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Lymph Node Molecular Analysis with OSNA Enables the Identification of pT1 CRC Patients at Risk of Recurrence, A Multicentre Study

  • Saez de Gordoa, Karmele|||0000-0001-8106-6121
  • Rodrigo Calvo, María Teresa|||0000-0001-6675-3425
  • Archilla, Ivan|||0000-0002-2142-0608
  • López-Prades, Sandra|||0000-0001-8208-2959
  • Díaz, Alba|||0000-0002-0456-7085
  • Tarragona, Jordi|||0000-0002-1459-4087
  • Machado, Isidro|||0000-0001-7318-1330
  • Ruiz Martín, Juan
  • Zaffalon, Diana|||0000-0001-6099-9694
  • Daca-Alvarez, Maria|||0000-0001-5636-8865
  • Pellisé, Maria|||0000-0001-9739-4998
  • Camps Polo, Jordi|||0000-0003-2929-4228
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
Early-stage colorectal carcinoma (CRC)-pT1-is a therapeutic challenge and presents some histological features related to lymph node metastasis (LNM). A significant proportion of pT1 CRCs are treated surgically, resulting in a non-negligible surgical-associated mortality rate of 1.5-2%. Among these cases, approximately 6-16% exhibit LNM, but the impact on survival is unclear. Therefore, there is an unmet need to establish an objective and reliable lymph node (LN) staging method to optimise the therapeutic management of pT1 CRC patients and to avoid overtreating or undertreating them. In this multicentre study, 89 patients with pT1 CRC were included. All histological features associated with LNM were evaluated. LNs were assessed using two methods, One-Step Nucleic Acid Amplification (OSNA) and the conventional FFPE plus haematoxylin and eosin (H&E) staining. OSNA is an RT-PCR-based method for amplifying CK19 mRNA. Our aim was to assess the performance of OSNA and H&E in evaluating LNs to identify patients at risk of recurrence and to optimise their clinical management. We observed an 80.9% concordance in LN assessment using the two methods. In 9% of cases, LNs were found to be positive using H&E, and in 24.7% of cases, LNs were found to be positive using OSNA. The OSNA results are provided as the total tumour load (TTL), defined as the total tumour burden present in all the LNs of a surgical specimen. In CRC, a TTL ≥ 6000 CK19 m-RNA copies/µL is associated with poor prognosis. Three patients had TTL.